Key result
COVID-19-related SCAD appears driven by systemic and localized inflammation.
Why the study?
The pathophysiology and management of spontaneous coronary artery dissection remain a matter of debate, and its relationship with COVID-19 remains unclear.
This review and case report highlights the pathophysiology and management of SCAD, particularly noting its potential association with COVID-19-related systemic and localized vascular inflammation.
Spontaneous coronary artery dissection (SCAD) accounts for 1-4% of all acute coronary syndromes (ACS). Since the first description in 1931, our understanding of the disease has evolved; however, its pathophysiology and management are still a matter of debate. SCAD typically occurs in a middle-aged woman with no or few traditional cardiovascular risk factors. Two hypotheses have been proposed to explain the pathophysiology depending on the primary event: an intimal tear in the "inside-out" hypothesis and a spontaneous hemorrhage from the vasa vasorum in the "outside-in" hypothesis. Etiology appears to be multifactorial: different predisposing and precipitating factors have been identified. Coronary angiography is the gold standard for the diagnosis of SCAD. Current recommendations on the treatment of SCAD patients are based on expert opinions: a conservative strategy is preferred in hemodynamically stable SCAD patients, while urgent revascularization should be considered in hemodynamically unstable patients. Eleven cases of SCAD in COVID-19 patients have already been described: although the exact pathophysiological mechanism remains unclear, COVID-19-related SCAD is considered a combination of significant systemic inflammatory response and localized vascular inflammation. We present a literature review of SCAD, and we report an unpublished case of SCAD in a COVID-19 patient.
No takes yet. Share an insight, caveat, or question.
Cosma et al. (2023) conducted a review in Spontaneous coronary artery dissection (SCAD). A review of spontaneous coronary artery dissection (SCAD) and analysis of 11 previously described COVID-19-related cases suggests the condition is driven by systemic and localized inflammation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: